When combined with mTOR inhibitor rapamycin, SMURF1 silencing resulted in the increased tumor sensitivity to rapamycin leading to significant inhibition of tumor growth in an orthotopic GB model (164). The gene discussed is SMURF1; the disease is neoplasm.